TANG CAPITAL MANAGEMENT LLC Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$497.2B
Holdings
29
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (29 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ANABANAPTYSBIO INC | 2,628,678 | $91.3B | 18.37% | |
| 2 | HRTXHERON THERAPEUTICS INC | 7,782,928 | $71.1B | 14.29% | |
| 3 | RCKTROCKET PHARMACEUTICALS INC | 2,531,800 | $55.3B | 11.12% | |
| 4 | —LA JOLLA PHARMACEUTICAL CO | 9,607,934 | $44.7B | 8.99% | |
| 5 | 5E7ITEOS THERAPEUTICS INC | 937,500 | $43.6B | 8.78% | |
| 6 | CCXIEURCHEMOCENTRYX INC | 500,000 | $18.2B | 3.66% | |
| 7 | —ODONATE THERAPEUTICS INC | 12,767,435 | $17.2B | 3.47% | |
| 8 | ALTALTIMMUNE INC | 1,600,000 | $14.7B | 2.95% | |
| 9 | BSFAANI PHARMACEUTICALS INC | 300,000 | $13.8B | 2.78% | |
| 10 | ALLKGUSDALLAKOS INC | 1,323,393 | $13.0B | 2.61% | |
| 11 | IMGNEURIMMUNOGEN INC | 1,500,000 | $11.1B | 2.24% | |
| 12 | —VINCERX PHARMA INC | 1,030,634 | $10.5B | 2.11% | |
| 13 | CHRSCOHERUS BIOSCIENCES INC | 650,000 | $10.4B | 2.09% | |
| 14 | BLUBELLUS HEALTH INC NEW | 1,200,000 | $9.7B | 1.94% | |
| 15 | LEGNLEGEND BIOTECH CORP | 200,000 | $9.3B | 1.87% | |
| 16 | ATYRATYR PHARMA INC | 1,113,453 | $8.3B | 1.67% | |
| 17 | LPTXEURLEAP THERAPEUTICS INC | 2,500,000 | $8.1B | 1.63% | |
| 18 | CRVSCORVUS PHARMACEUTICALS INC | 3,101,709 | $7.5B | 1.50% | |
| 19 | BCABBIOATLA INC | 297,914 | $5.8B | 1.18% | |
| 20 | ONCBEIGENE LTD | 20,000 | $5.4B | 1.09% | |
| 21 | —RADIUS HEALTH INC | 763,888 | $5.3B | 1.06% | |
| 22 | GNFTYGENFIT S A | 1,055,994 | $5.3B | 1.06% | |
| 23 | TNGXTANGO THERAPEUTICS INC | 468,750 | $5.1B | 1.03% | |
| 24 | —REVIVA PHARMACEUTCLS HLDGS I | 1,200,000 | $3.5B | 0.70% | |
| 25 | —CALLIDITAS THERAPEUTICS AB | 100,000 | $2.5B | 0.50% | |
| 26 | —ASLAN PHARMACEUTICALS LTD | 2,054,925 | $2.3B | 0.46% | |
| 27 | EQEQUILLIUM INC | 600,000 | $2.3B | 0.45% | |
| 28 | RLMDRELMADA THERAPEUTICS INC | 59,122 | $1.3B | 0.27% | |
| 29 | CTMXCYTOMX THERAPEUTICS INC | 152,345 | $660.0M | 0.13% |